|
MKRN1 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.123700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.363900E-02 |
| Normal-vs-Stage2 |
7.434000E-02 |
| Normal-vs-Stage3 |
8.583600E-04 |
| Normal-vs-Stage4 |
1.539550E-03 |
| Stage1-vs-Stage2 |
9.202600E-01 |
| Stage1-vs-Stage3 |
6.959600E-02 |
| Stage1-vs-Stage4 |
9.213700E-02 |
| Stage2-vs-Stage3 |
2.608400E-01 |
| Stage2-vs-Stage4 |
2.211800E-01 |
| Stage3-vs-Stage4 |
7.738000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.640600E-03 |
| Normal-vs-AfricanAmerican |
1.403960E-01 |
| Normal-vs-Asian |
3.862100E-02 |
| Caucasian-vs-AfricanAmerican |
7.501600E-01 |
| Caucasian-vs-Asian |
7.076800E-01 |
| AfricanAmerican-vs-Asian |
9.251400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.320000E-03 |
| Normal-vs-Female |
5.975100E-03 |
| Male-vs-Female |
8.747200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.798100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.581570E-02 |
| Normal-vs-Age(61-80Yrs) |
2.435300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.141600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.632600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.979660E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.830210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.784200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.012000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.286800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.659100E-03 |
| Classical-VS-Follicular |
2.591600E-01 |
| Classical-VS-Other |
9.777400E-01 |
| Classical-VS-Normal |
2.701600E-02 |
| Tall-VS-Follicular |
1.363400E-01 |
| Tall-VS-Other |
4.990800E-01 |
| Tall-VS-Normal |
1.392880E-04 |
| Follicular-VS-Other |
7.591400E-01 |
| Follicular-VS-Normal |
1.664130E-02 |
| Other-VS-Normal |
4.225800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.640500E-03 |
| Normal-vs-N1 |
9.985000E-04 |
| N0-vs-N1 |
1.326200E-01 |
|
|
